Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

This study has been completed.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: June 4, 2004
Last updated: May 17, 2012
Last verified: May 2012